Declaration of Competing Interest statements were not included in published version of the following articles that appeared in previous issues of Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Hence, the authors of the below articles were contacted after publication to request a Declaration of Interest statement:
-
1.
“Breakthrough COVID19 Infections after Vaccinations in Healthcare and Other Workers in a Chronic Care Medical Facility in New Delhi, India” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (3): 1007–1008] https://doi.org/10.1016/j.dsx.2021.05.001
-
2.
“Brain insulin resistance as a mechanistic mediator links peripheral metabolic disorders with declining cognition” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2022; 16 (4)] https://doi.org/10.1016/j.dsx.2022.102468
-
3.
“Long COVID: An overview” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (3): 869–875] https://doi.org/10.1016/j.dsx.2021.04.007
-
4.
“Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (6): 2233–2239] https://doi.org/10.1016/j.dsx.2020.11.015
-
5.
“Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central India” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (6): 1571–1574] https://doi.org/10.1016/j.dsx.2020.08.012
-
6.
“Diabetes mellitus and the impairment of male reproductive function: Possible signaling pathways” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 1307–1314] https://doi.org/10.1016/j.dsx.2020.07.031
-
7.
“The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral foot of patients admitted with a diabetic foot ulcer” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (3): 857–862] https://doi.org/10.1016/j.dsx.2021.03.023
-
8.
“Prediction and early detection of cardiovascular disease in South Asians with diabetes mellitus” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 385–393] https://doi.org/10.1016/j.dsx.2020.04.017
-
9.
“Application of cognitive Internet of Medical Things for COVID-19 pandemic” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 911–915] https://doi.org/10.1016/j.dsx.2020.06.014
-
10.
“COVID-19 Pandemic and Challenges for Socio-economic Issues, Healthcare and National Programs in India” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 757–759] https://doi.org/10.1016/j.dsx.2020.05.041
-
11.
“Escalating cost of oral and injectable antihyperglycemic drugs; are newer medications worth their price? A perspective from India and other developing countries.” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (2): 167–169] https://doi.org/10.1016/j.dsx.2020.01.012
-
12.
“Cardiovascular disease and COVID-19” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (3): 247–250] https://doi.org/10.1016/j.dsx.2020.03.013
-
13.
“Doctors and Healthcare Workers at Frontline of Covid 19 Epidemic: Admiration, A Pat on the Back, and Need for Extreme Caution” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (3): 255–256] https://doi.org/10.1016/j.dsx.2020.03.006
-
14.
“Impact of diabetes on the severity of COVID-19 infection in pregnant women - A single-center descriptive study” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 16 (1)] https://doi.org/10.1016/j.dsx.2021.102362
-
15.
“Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 273–276] https://doi.org/10.1016/j.dsx.2020.04.001